FDA Recalls Compounded Omnipaque Injectable Due to Sterility Concerns
Oregon Compounding Centers is recalling compounded Omnipaque injectable vials due to quality control issues affecting sterility assurance.
- Product
- OMNIPAQUE, 300mgI/mL, injectable, 2 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
- Category
- Drug
- Distribution
- 2 states